<p>Homogenized insoluble fractions from human brain samples (n = 8) were incubated with increasing concentrations of [<sup>125</sup>I]SIL23. Nonspecific binding was determined in parallel reactions utilizing 50 µM ThioT as competitor. Representative plots of specific binding versus [<sup>125</sup>I]SIL23 concentration are shown. <b>A–D</b> show four different PD cases and <b>E–H</b> show four control cases. The data was analyzed by curve fitting to a one-site binding model using nonlinear regression. K<sub>d</sub> values for binding to PD-dementia brain samples range from 119.1 nM to 168.3 nM and B<sub>max</sub> values range from 13–25 pmol/mg insoluble protein. No significant binding of [<sup>125</sup>I]SIL23 to control samples was observe...
Non-invasive determination of amyloid- peptide (Aβ) deposition with radioligands serves for the earl...
<p>Specific [<sup>3</sup>H]PiB binding to mouse and human brain homogenates and nonlinear modeling o...
The aggregation of the 42-residue form of the amyloid-β peptide (Aβ42) is a pivotal event in Alzheim...
<p>Levels of α-syn were measured in insoluble fractions from human brain samples (n = 10) by sequent...
Accumulation of a-synuclein (a-syn) fibrils in Lewy bodies and Lewy neurites is the pathological hal...
<div><p>Accumulation of α-synuclein (α-syn) fibrils in Lewy bodies and Lewy neurites is the patholog...
<p>Fibrils prepared from recombinant α-syn were incubated with increasing concentrations of [<sup>12...
The accumulation of amyloid fibrils is characteristic of neurodegenerative diseases such as Alzheime...
<p>In vitro binding potential (BP) as yielded with [<sup>3</sup>H]PiB radioligand saturation binding...
Parkinson's disease (PD) and dementia with Lewy bodies (DLB) are both characterized by the formation...
The progressive neurodegeneration in Alzheimer’s disease is believed to be linked to the presence of...
Dementia with Lewy bodies (DLB) is pathologically characterized by the presence of alpha-synuclein-c...
significantly higher PiB retention in the gray matter of Alzheimer disease (AD) patients than in hea...
Fluorine-18 labelled N,N-diethyl-2-(2-[4-(2-fluoroethoxy)phenyl]-5,7-dimethylpyrazolo[1,5-α]pyrimidi...
ObjectiveAlzheimer's disease (AD) is a neurodegenerative disease characterized by aggregation of Tau...
Non-invasive determination of amyloid- peptide (Aβ) deposition with radioligands serves for the earl...
<p>Specific [<sup>3</sup>H]PiB binding to mouse and human brain homogenates and nonlinear modeling o...
The aggregation of the 42-residue form of the amyloid-β peptide (Aβ42) is a pivotal event in Alzheim...
<p>Levels of α-syn were measured in insoluble fractions from human brain samples (n = 10) by sequent...
Accumulation of a-synuclein (a-syn) fibrils in Lewy bodies and Lewy neurites is the pathological hal...
<div><p>Accumulation of α-synuclein (α-syn) fibrils in Lewy bodies and Lewy neurites is the patholog...
<p>Fibrils prepared from recombinant α-syn were incubated with increasing concentrations of [<sup>12...
The accumulation of amyloid fibrils is characteristic of neurodegenerative diseases such as Alzheime...
<p>In vitro binding potential (BP) as yielded with [<sup>3</sup>H]PiB radioligand saturation binding...
Parkinson's disease (PD) and dementia with Lewy bodies (DLB) are both characterized by the formation...
The progressive neurodegeneration in Alzheimer’s disease is believed to be linked to the presence of...
Dementia with Lewy bodies (DLB) is pathologically characterized by the presence of alpha-synuclein-c...
significantly higher PiB retention in the gray matter of Alzheimer disease (AD) patients than in hea...
Fluorine-18 labelled N,N-diethyl-2-(2-[4-(2-fluoroethoxy)phenyl]-5,7-dimethylpyrazolo[1,5-α]pyrimidi...
ObjectiveAlzheimer's disease (AD) is a neurodegenerative disease characterized by aggregation of Tau...
Non-invasive determination of amyloid- peptide (Aβ) deposition with radioligands serves for the earl...
<p>Specific [<sup>3</sup>H]PiB binding to mouse and human brain homogenates and nonlinear modeling o...
The aggregation of the 42-residue form of the amyloid-β peptide (Aβ42) is a pivotal event in Alzheim...